跳至主要内容
临床试验/EUCTR2009-010804-27-IT
EUCTR2009-010804-27-IT进行中(未招募)不适用

ROLE OF NITRIC OXIDE IN LUNG INFLAMMATION OF COPD PATIENTS - ND

AZIENDA OSPEDALIERA POLICLINICO DI MODENA0 个研究点开始时间: 2009年7月30日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • COPD outpatients in stage II and III of GOLD classification. Patients will be smokers or ex-smokers since at least 6-months, with a similar degree of severity, while on their usual drug therapy.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • No actual use of steroids or antioxidants (i.e. N-acetilcysteine), no evidence of exacerbation in the preceeding 4 weeks.

研究者

发起方
AZIENDA OSPEDALIERA POLICLINICO DI MODENA

相似试验